Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer
Public ClinicalTrials.gov record NCT03290508. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Long-Term Prospective Registry to Evaluate Treatment Decisions and Clinical Outcomes in Patients With Favorable Intermediate-Risk Localized Prostate Cancer Following Cell Cycle Progression (CCP) Testing (Prolaris® Test)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a long-term prospective registry study to determine whether Prolaris testing in patients with favorable intermediate risk prostate cancer influences physician management decisions toward conservative treatment in patients with Prolaris low-risk scores without negatively impacting patient oncologic outcomes, thereby sparing low-risk patients from unnecessary treatments and associated side-effects.
Study identification
- NCT ID
- NCT03290508
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 524 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 14, 2017 (Actual)
- Primary completion
- Jan 14, 2022 (Actual)
- Completion
- Jan 14, 2022 (Actual)
- Last update posted
- Jun 23, 2022
2017 – 2022
United States locations
- U.S. sites
- 34
- U.S. states
- 21
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Urology Centers of Alabama | Homewood | Alabama | 35209 | — |
| East Valley Urology Center | Mesa | Arizona | 85206 | — |
| University of Arkansas for Medical Sciences | Little Rock | Arkansas | 72205 | — |
| Arkansas Urology | Little Rock | Arkansas | 72211 | — |
| Pacific Urology | Concord | California | 94520 | — |
| VA Long Beach Healthcare | Long Beach | California | 90822 | — |
| UCI Medical Center | Orange | California | 92866 | — |
| Ssg Md Apc | San Jose | California | 95124 | — |
| Advanced Urology Institute | Daytona Beach | Florida | 32114 | — |
| Urology Group of Florida | Delray Beach | Florida | 33484 | — |
| Pinellas Urology | St. Petersburg | Florida | 33710 | — |
| 21st Century Oncology | Sunrise | Florida | 33351 | — |
| Meridian Clinical Research | Savannah | Georgia | 31405 | — |
| North Idaho Urology | Coeur d'Alene | Idaho | 83814 | — |
| URO Partners | Westchester | Illinois | 60154 | — |
| Wichita Urology | Wichita | Kansas | 67226 | — |
| Regional Urology | Shreveport | Louisiana | 71106 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| University of Michigan, Department of Urologic Oncology | Ann Arbor | Michigan | 48109 | — |
| Comprehensive Urology | Royal Oak | Michigan | 48073 | — |
| Michigan Institute of Urology | Troy | Michigan | 48084 | — |
| UroLogic | Tupelo | Mississippi | 38801 | — |
| Premier Urology Group, LLC | Cranford | New Jersey | 07016 | — |
| Premier Urology | Cranford | New Jersey | 07016 | — |
| Urologic Research and Consulting LLC | Englewood | New Jersey | 07631 | — |
| Stony Brook University | Stony Brook | New York | 11794 | — |
| A.M.P. Radiation Oncology | Syracuse | New York | 13210 | — |
| Associated Urologists of North Carolina | Raleigh | North Carolina | 27612 | — |
| Lehigh Valley Health Network | Allentown | Pennsylvania | 18103 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Carolina Urology Partners | West Columbia | South Carolina | 29163 | — |
| Urology Associates | Nashville | Tennessee | 37209 | — |
| Rio Grande Urology | El Paso | Texas | 79912 | — |
| Seattle Urology Research Center | Burien | Washington | 98166 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03290508, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2022 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03290508 live on ClinicalTrials.gov.